WilliamFrancisFinnMD

PubMed

• 126 citations
  The clinical and renal consequences of contrast-induced nephropathy.
  William F. Finn
  Nephrology, Dialysis, Transplantation. 2006-06-01
• 91 citations
  The Phosphate Binder Equivalent Dose
  John T. Daugirdas, William F. Finn, Michael Emmett, Glenn M. Chertow
  Seminars in Dialysis. 2011-01-01
• 72 citations
  Efficacy and safety of lanthanum carbonate for reduction of serum phosphorus in patients with chronic renal failure receiving hemodialysis.
  William F. Finn, Melanie S. Joy, G Hladik
  Clinical Nephrology. 2004-09-01

Journal Articles

• Kidney Disease and Gout: The role of the innate immune system  
  Finn WF, The Open Urology & Nephrology Journal, 1/1/2016
• Comparison of Phosphorus Binding Capacity Sevelamer and Lanthanum  
  Finn WF, 33rd Annual Dialysis Conference, 1/12/2013
• Double-Blind, Dose-Ranging, Study of Lanthanum Dioxycarbonate (SPI-014, RenaZorb) in Healthy Volunteers Shows High Phosphorus Binding Capacity  
  Finn WF, Denu-Ciocca CJ, Joy MS, et al, American Society of Nephrology Annual Meeting, 1/5/2013
• Importance of understanding phosphate binding capacity of sevelamer and lanthanum in relation to dietary protein intake in chronic hemodialysis patients  
  Finn WF, Spring Clinical Meetings, National Kidney Foundation, 1/2/2013
• Successful treatment of gout with febuxostst (Uloric) in stage 4 chronic kidney disease patients  
  Finn WF, ERA-EDTA Congress, 1/23/2011
• The Phosphate Binder Equivalent Dose  
  Daugirdas JT, Finn WF, Emmett ME, Chertow GM, Frequent Hemodialysis Study Group, Seminars in Dialysis, 1/1/2011
• Lanthanum carbonate (LC) treatment does not affect 25-hyrdoxyvitamin D (25-OH) and 1,25-dihydroxyvitamin D (!,25-(OH)2 D) levels in patients with CKD stages 3 and 4: A...  
  Finn, W, Sprague S, Abboud H, Qiu P, National Kidney Foundation�s Clinical Meeting, 1/25/2009
• Estimation of dietary phosphorus intake from normalized protein catabolic rate in chronic hemodialysis patients: Importance in maintaining phosphorus balance  
  Finn WF, World Congress of Nephrology, 1/25/2009
• Lanthanum carbonate reduces phosphorus burden in patients with CKD stages 3 and 4: a randomized trial  
  Sprague SM, Abboud H, Qiu P, Dauphin M, Zhang P, Finn W, Clin J Am Soc Nephrol, 1/1/2009
• Lanthanum carbonate treatment, for up to 6 years, is not associated with adverse effects on the liver in patients with chronic kidney disease Stage 5 receiving hemodia...  
  Hutchison AJ, Barnett ME, Krause R, J, Siami GA, Lanthanum Carbonate Study Group, Clin Nephrol, 1/1/2009
• 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels in patients with CKD stages 3 and 4 not affected by lanthanum carbonate: Results from a randomized multicenter t...  
  Finn WF, Sprague S, Abboud H, Qui P, ERA-EDTA XLV Congress, 1/10/2008
• Lanthanum carbonate reduces calcium x phosphate product in patients with CKD stages 3 and 4: Results from a randomized multicenter trial  
  Finn WF, Sprague S, Abboud H, Qui P, ERA-EDTA XLV Congress, 1/10/2008
• Lanthanum carbonate reduces phosphate burden in patients with CKD stage 3 and 4: Results from a randomized multicenter trial  
  Sprague S, Finn W, Abboud H, Qui P, ERA-EDTA XLV Congress, 1/10/2008
• Urinary phosphorus excretion is a valuable measure of total body phosphorus burden in patients with CKD stages 3 and 4  
  Finn W and Kingman-Johnson I, American Society of Nephrology Annual Meeting, 1/6/2008
• Lanthanum carbonate reduces phosphate burden in patients with CKD stages 3 and 4: Results from a randomized multicenter trial  
  Sprague S, Finn W, Abboud H, Qui P on behalf of the SPD405-206 study investigators, National Kidney Foundation�s Clinical Meeting, 1/3/2008
• Higher strength lanthanum carbonate provides serum phosphorus control with a low tablet burden and is preferred by patients and physicians: a multicenter study  
  Mehrotra R, Martin KJ, Fishbane S, Sprague SM, Zeig S, Anger M; Fosrenol Overview Research Evaluation Study for Early Experience Study Group, Clin J Am Soc Nephrol, 1/1/2008
• Ergocalciferol effectively lowers iPTH levels in chronic kidney disease (CKD) patients  
  Finn WF, Am J Kidney Dis; National Kidney Foundation�s Clinical Meeting, 1/12/2007
• Cytochrome P450 3A5 Expression in the Kidneys May Modulate Calcineurin Inhibitor Nephrotoxicity  
  Joy MS, Hogan SL, Thompson BD, Finn WF, Nickeleit V, Nephrol Dial Transplant, 1/1/2007
• Lanthanum carbonate versus standard therapy for the treatment of hyperphosphatemia: Safety and efficacy in chronic maintanience hemodialysis patients  
  Finn WF, Clin Nephrol, 1/1/2006
• The clinical and renal consequences of a constract-induced nephropathy  
  Finn William F, Nephrol Dial Transplant, 1/1/2006
• Non-contrasted-enhanced computerized Tomography and Analgesic-Related Kidney Disease: Report of the National Analgesic Nephropathy Study  
  Henrich WL, Clark RL, Kelly JP, Buckalew VM, Fenves A, Finn WF, Shapiro JI, Kimmel PL, Eggers P, Agodoa LE, Porter GA, Shapiro Toto R, S, Anderson T, Cupples LA and Ka..., J Am Soc Nephrol, 1/1/2006
• Immunosuppression, Hepatitis C Infection, and Acute Renal Failure in HIV-infected Patients  
  Franceschini N, Napravnik S, Finn WF, Szczech LA, Eror JJ Jr, J Acquir Immune Def Syndr, 1/1/2006
• Vitamin D Deficiency in Hemodialysis Patients with Stage V Chronic Kidney Disease  
  Finn WF, On Behalf of the SPD405-307 Lanthanum Study Group, 3rd World Congress of Nephrology, 1/26/2005
• The Clinical and Renal Consequences of Contrast-Induced Nephropathy  
  Finn WF, 3rd World Congress of Nephrology, 1/26/2005
• Analysis of Vitamin D and K Levels in Patients with ESRD Enrolled into a Clinical Trial: Evidence for a High Incidence of Vitamin Deficiency  
  Finn WF, American Society of Nephrology Annual Meeting, 1/8/2005
• Join now to see all

Books/Book Chapters

• Primer on Kidney Disease 
  Chapter: Tubulointersititial Disease 
  Finn WFEditors: A Greenberg, AK Cheung, TM Coffman, RJ Falk, JC Jennette.Academic Press, San Diego, CAEdition 3rd,2001
• Acute Renal Failure: A Companion to Brenner and Rector�s The Kidney 
  Chapter: Recovery from Acute Renal Failure 
  Finn WFEditors: BA Molitoris and WF Finn.WB Saunders and Company, Philadelphia, PA2001
• Acute Renal Failure: A Companion to Brenner and Rector�s The Kidney 
  Finn WFEditors: BA Molitoris and WF Finn.WB Saunders and Company, Philadelphia, PA2001
• Primer on Kidney Disease 
  Chapter: Lead Nephropathy 
  Finn WFEditors: A Greenberg, AK Cheung, TM Coffman, RJ Falk, JC Jennette.Academic Press, San Diego, CAEdition 2nd,1998
• Primer on Kidney Disease 
  Chapter: Tubulointersititial Nephropathies 
  Finn WFEditors: A Greenberg, AK Cheung, TM Coffman, RJ Falk, JC Jennette.Academic Press, San Diego, CAEdition 2nd,1998
• Clinical Nephrotoxins: Renal Injury from Drugs and Chemicals 
  Chapter: Urinary Biomarkers and Nephrotoxicity 
  Finn WF and Porter GAEditors: GA Porter, ME De Broe, WM Bennett, GA Verpooten.Kluwer Academic Publishers, Dordrecht, The Netherlands; Boston, MA; London, England, United Kingdom1997
• Biologic Markers in Urinary Toxicology 
  Finn WF1995
• Internal Medicine 
  Chapter: Toxic nephropathy 
  Finn WFEditors: JH Stein.Mosby Year Book, St. Louis, MOEdition 4th,1994
• The Principles and Practice of Environmental Medicine 
  Chapter: Disorders of the kidney and urinary tract 
  Finn WFEditors: E Tarcher.Plenum Press, New York, NY1993
• Manual of Clinical Problems in Adult Ambulatory Care 
  Chapter: Edema states 
  Finn WFEditors: L Dornbrand, AJ Hoole, CG Pickard.Little Brown and Co., Boston, MAEdition 2nd,1992
• Current Therapy in Nephrology and Hypertension 
  Chapter: Conservative, nondialytic management of acute renal failure 
  Finn WFEditors: RT Glassock.Mosby Year Book, St. Louis, MO1991
• cute Renal Fialure: Diagnosis, Treatment and Prevention 
  Chapter: Acute renal failure caused by antibacterial, antifungal and antineoplastic agents 
  Page 49 - 86Dillon JJ and Finn WFEditors: K Solez and LC Racusen.Marcel Dekker, Inc., New York, NY1991
• Medical Clinics of North America 
  Chapter: Diagnosis and Mangement of Acute Tubular Necrosis 
  Finn WFEditors: AK Mandel, LA Herbert.WB Saunders, Co., Philadelphia, PA1990
• Renal Heterogeneity and Target Cell Toxicity 
  Chapter: N-acetyl-B-glucosaminidase excretion during cyclosporine A treatment 
  Finn WF and Gitelman HJEditors: P Bach, EA Lock.John Wiley & Sons Limited, Chichester, England, United Kingdom1985
• Manual of Clinical Problems in Ambulatory Care 
  Chapter: Edema states 
  Finn WFEditors: L Dornbrand, R Fletcher. AJ Hoole, CG Pickard.Little, Brown and Co., Boston, MA1985
• Controversies in Nephrology - Volume IV 
  Chapter: The use of nephrotoxic agents during recovery from acute renal failure 
  Finn WF, Fernandez-Repollet E and Gitelman HJEditors: GE Schreiner and JF Winchester.Nephrology Division, Georgetown University1984
• Acute Renal Failure - Correlations Between Morphology and Function 
  Chapter: Relative importance of volume depletion and tubular damage in gentamicin-induced acute renal failure 
  Fernandez-Repollet E and Finn WFEditors: K Solez and A Whelton.Marcel Dekker, Inc., New York, NY1984
• Acute Renal Failure 
  Chapter: Recovery from acute renal failure 
  Finn WFEditors: BM Brenner and JM Lazarus.W.B. Saunders Co., Boston, MA1983
• Acute Renal Failure 
  Chapter: Postischemic acute renal failure: Variation in the initial phase 
  Finn WFEditors: HE Eliahou.John Libbey, London, England, United Kindgom1982
• Acute Renal Failure 
  Chapter: Effect of contralateral nephrectomy on the initial phase of postischemic acute renal failure 
  Fernandez-Repollet E and Finn WFEditors: HE Eliahou.John Libbey, London, England, United Kindgom1982
• Strauss and Welt's Disease of the Kidney 
  Chapter: Acute renal failure 
  Finn WFEditors: LE Earley and CW Gottschalk.Little, Brown and Co., Boston, MAEdition 3rd,1979
• Join now to see all

Abstracts/Posters

• Autoregulation of blood flow in the rat kidney
  Arendshorst WJ, Finn WF and Gottschalk CW, The Physiologist; Fall Meeting of the American Physiological Society, Albany, NY, 1/11/1974
• Effect of a 24-hour obstruction to tubular flow on stop-flow pressures in the rat
  Finn WF, Arendshorst WJ and Gottschalk CW, Clin Res; Southern Society for Clinical Investigations, New Orleans, LA, 1/1/1974
• Pathogenesis of acute renal insufficiency after temporary renal ischemia in the rat
  Arendshorst WJ, Finn WF and Gottschalk CW, Abstracts of the American Society of Nephrology; 6th Annual Meeting of the American Society of Nephrology, Washington, DC, 1/1/1973

Lectures

• Management of the Phosphorus Burden in Chronic Kidney Disease 
  Taipei, Taiwan - 1/28/2013
• Management of Phosphate and Calcium Burden in Chronic Kidney Disease Patients 
  Multiple locations, 2013 - 1/14/2013
• Phosphate-Binder Dose-Response Curves: Sevelamer versus Lanthanum 
  Seattle, WA - 1/12/2013
• Hyperuricemia, Gout and the Kidney: Issues and Considerations in the Care of the Patient with Chronic Renal Disease 
  Taipei, Taiwan - 1/10/2013
• Hyperuricemia, gout and Chronic Kidney disease 
  Greensboro, NC - 1/23/2012
• Role of diet in the progression of chronic kidney disease 
  Kyllini, Greece - 1/15/2012
• Hyperuricemia and Gout: A Neglected Component in the Care of the Patient with Chronic Kidney Disease 
  University of Tennessee Medical School, Knoxville, TN - 1/11/2012
• Managing hyperphosphatemia beyond dialysis 
  Messinia, Greece - 1/17/2011
• Hyperuricemia and Gout: A Nephrologist�s Perspective 
  Eastern Virginia Medical School, Norfolk, VA - 1/3/2010
• Phosphorus Balance in Chronic Kidney Disease 
  Las Vegas, NV - 1/28/2009
• Management of the Phosphorus Burden in Chronic Kidney Disease: Achieving Proper Balance with the Correct Choice and Dose of Phosphorus-Binding Agents 
  Philadelphia, PA, 2008; Bonita Springs, FL, 2009 - 1/15/2009
• Vitamin D Deficiency in Patinets with Chronic Kidney Disease 
  Chicago, IL - 1/28/2008
• �Radiocontrast Nephropathy 
  Taipei, Taiwan - 1/15/2008
• Phosphorus Balance 
  Taipei, Taiwan - 1/13/2008
• Uremic Toxicity in Acute Kidney Injury 
  Salvador, Brazil - 1/27/2007
• Mechanisms of Renal Recovery � New Therapeutic Possibilities 
  Rio de Janeiro, Brazil - 1/24/2007
• The Clinical Issues Surrounding the Management of Chronic Kidney Disease: The Impact of Vitamin D Deficiency and Hyperphosphatemia 
  Mineola, Long Island, NY - 1/19/2006
• Soft Tissue Calcification in Chronic Kidney Disease: The Role of Hyperphosphatemia 
  Multiple locations, 2006 - 1/18/2006
• Treatmant Options for the Management of Hyperphosphatemia and Vitamin D Deficiency 
  Halifax Medical Center, Daytona Beach, FL - 1/10/2006
• Management of Hyperphosphatemia in Chronic Kidney Disease 
  1/4/2006
• The Clinical and Renal Consequences of Contrast-Induced Nephroathy 
  Singapore - 1/29/2005
• Radiocontrast Nephropathy 
  Toronto, Canada - 1/2/2004
• The Devil and Saint Benedict: Lessons in Acute Renal Failure 
  Chicago, IL - 1/25/2003
• Management of Hyperphosphatemia in Patients with End-Stage Renal Disease 
  Pattaya, Thailand, 2003; Kuala Lumpur, Malaysia, 2003 - 1/22/2003
• Acute Renal Faiure and Cox II Inhibitors 
  Rio de Janeiro, Brazil - 1/17/2000
• Join now to see all

Other

• Clinical Challenges and Renal Considerations inManaging Gout 
  Finn WF, Renal and Urology News
  1/1/2012
• Chronic Kidney Disease, Volume 3. Diabetic Patients with Gastroparesis and Chronic Kidney Disease�Management of Malnutrition: An Expert Interview with William F. Finn, MD 
  Finn WF, Medscape Nephrology
  1/28/2006
• Management of Hyperphosphatemia: focus on K/DOQI Guidelines 
  Finn WF, Medscape Nephrology
  1/22/2005
• Chronic Kidney Disease Expert Column. Phosphorus Binders: Relative Potency of Available Agents 
  Finn WF, Medscape Nephrology
  1/16/2005
• Gout, Hyperuricemia, and Chronic Kidney Disease: Optimizing Patient Management 
  Wortmann R, Finn WF, Hilas O, National Kidney Foundation
  http://opencme.org/course/gout-hyperuricemia-and-chronic-kidney-disease-optimizing-patient-management
• Join now to see all